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Rous sarcoma virusretroviral integrases contains an Asp,Asp-35-Glu (D,D-35-E) motif with precisely
35 amino acids between the second aspartate and the glutamate. We have now made several mutations
designed to alter the length or ﬂexibility of a mobile loop within this 35-amino-acid spacer region in full-
length Rous sarcoma virus integrase. Surprisingly, most of the mutants had enzymatic activity, including ones
that shortened or lengthened the loop by up to 6 amino acids. Several size mutants exhibited the two
biologically relevant activities of integrase in reactions with Mn2+, although they were inactive with Mg2+. No
viruses containing integrase with an altered length, however, replicated in cell culture, and these viruses
were blocked at the integration step. Thus, the conserved 35-amino-acid spacing is not absolutely required
for enzymatic activity, but the correlation between infectivity and Mg2+-dependent activity supports
magnesium as the metal cofactor used by integrase in vivo.
© 2008 Elsevier Inc. All rights reserved.Introduction
Integration of a copy of the retroviral genome into cellular DNA
is required for retrovirus replication and leads to neoplastic,
neurologic, and immunodeﬁciency diseases. To mediate integration,
the viral integrase catalyzes two endonuclease reactions that can be
modeled with puriﬁed proteins and oligonucleotide substrates.
Integrase ﬁrst processes the 3′ ends of linear viral DNA by removing
two nucleotides that follow conserved CA bases (Katzman et al.,
1989), then joins the trimmed ends of the processed viral DNA to
cellular DNA at nicks that are created independently of the target
sequence (Craigie et al., 1990; Katz et al., 1990). The enzymatic
activities of integrase reside in its central or core domain, which on
its own is not sufﬁcient to catalyze processing or joining but can
catalyze two other in vitro endonuclease reactions: disintegration
and nonspeciﬁc alcoholysis (Bushman et al., 1993; Katzman and
Sudol, 1996).
The central domains of the human immunodeﬁciency virus type 1
(HIV-1) and avian sarcoma virus (ASV) integrases have been crystal-
lized, and their structures place them in a family of polynucleotidyl
transferases (Bujacz et al., 1995; Dyda et al., 1994). The core domain ofivision of Infectious Diseases,
ilton S. Hershey Medical Center,
SA. Fax: +1717 531 4633.
l rights reserved.all retroviral integrases has three conserved acidic residues arranged
as Asp-(variable gap)-Asp-(35 amino acids)-Glu , referred to as the D,
D-35-E motif (Fig. 1) (Kulkosky et al., 1992). This motif is also
conserved in retrotransposon integrases and the transposases of many
bacterial insertion sequence elements (Fayet et al., 1990; Khan et al.,
1991; Kulkosky et al., 1992; Rowland and Dyke, 1990), although there
is some variability in spacing between the second and third conserved
residues in those settings (Doak et al., 1994; Khan et al., 1991;
Kulkosky et al., 1992). Although it has been shown that mutations at
any of these three sites in retroviral integrase can knock out all
enzymatic activities (Drelich et al., 1992; Engelman and Craigie, 1992;
Kulkosky et al., 1992; LaFemina et al., 1992; Leavitt et al., 1993; van
Gent et al., 1992), the reason that the 35-amino-acid spacing is
invariant in retroviral integrases remains unknown.
Within the 35-amino-acid spacer in the D,D-35-E region, there is a
short stretch of amino acids that is disordered or mobile in crystals of
HIV-1 and ASV integrases (Fig. 1) (Bujacz et al., 1995; Dyda et al., 1994).
The disordered loop for HIV-1 integrasewas originally deﬁned as amino
acids 141 to 153 (Dyda et al.,1994), but laterwork reduced its boundaries
to 141 and 148 (Greenwald et al., 1999) and the amount of order
observed in this region is dependent on experimental conditions (Chen
et al., 2000;Goldgur et al.,1998; Lins et al.,1999;Maignan et al.,1998). In
the case of ASV integrase, the corresponding loop extends approxi-
mately from residues 144 to 153, depending on conditions (Bujacz et al.,
1995; Lubkowski et al., 1999; Yang et al., 2000). The precise role of this
loop remains undeﬁned, but it has been implicated in critical enzyme-
substrate interactions (Esposito and Craigie, 1998; Gerton et al., 1998;
Fig. 1. Sequences and mutants. Top: The central domain of integrase (with its D,D-35-E motif) is shown schematically. Middle: The amino-acid sequences of the D-35-E region of the
integrases of HIV-1 (strain pNL4-3) and RSV are aligned, with identity indicated by vertical bars and amino-acid numbers provided for key residues or ones discussed in the text. The
invariant D and E are highlighted by shaded ovals, and structural elements – including three alpha helices and one beta sheet as initially deﬁned for each protein (Bujacz et al., 1995;
Dyda et al., 1994) – are boxed and labeled α2, α3, β5, and α4 (the sequence of this region of RSV integrase is identical to that of the ASV integrase for which crystal structures have
been reported). The horizontal bracket indicates the disordered or mobile loop, with ﬁlled circles indicating 3 glycines in the RSV sequence, and the ﬁlled square indicating a
conserved proline. Bottom: The table shows mutations created between RSV residues 144 and 153, with the wild-type sequence as the ﬁrst entry. Dashes indicate identity to wild-
type, spaces beneath wild-type residues indicate deletions, and letters not aligned with a wild-type residue denote insertions. Also shown are the sizes of this loop region and the
resultant spacing in the D,D-35-Emotif (the “x” in the D-x-E column), with dashes denoting no difference fromwild-type; the name assigned to eachmutant; and the rationale for the
mutation. Protein 7 (“AGA”) also included an unplanned A18S mutation. IN, integrase protein numbers as used in the text and in other ﬁgures; aa, amino acid.
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Interestingly, substituting the glycines at HIV-1 integrase residues 140
and 149 by themore-constrained alanine,whichwas shown to decrease
the mobility of this loop in crystals of the core domain, diminished the
catalytic activity of the core fragment in disintegration assays (Green-
wald et al., 1999). However, the effects of these substitutions in full-
length protein or in virus were not described.
We have now made several mutations that were designed to alter
the ﬂexibility or length of the mobile loop within the 35-amino-acid
spacer region in the catalytic domain of Rous sarcoma virus (RSV)
integrase. Importantly, all mutations were assessed in the context of
the full-length protein. The mutant proteins were tested in several in
vitro assays, and selected mutations were placed into virus and tested
during infections in cell culture. Together, these experiments address
the importance of this loop and the spacing within the catalytic
domain of this critical viral enzyme.
Results
Rationale for integrase mutations
Fig. 1 compares the D,D-35-E regions of the HIV-1 and RSV
integrases and describes 15 mutants that have changes in the loopfrom RSV integrase residues 144 to 153. Several of the mutations were
designed to alter the ﬂexibility of this loop because of the report that
substituting alanine for the glycines at HIV-1 integrase residues 140
and 149 decreased the mobility of this loop and diminished the
enzymatic activity of the core fragment (Greenwald et al., 1999).
Although the HIV-1 protein has only two glycines in this region (one
ﬂanking each end of the loop), the RSV protein has three glycines in
this region (one near each end and one near the middle of the loop, as
indicated by the ﬁlled circles in Fig.1). Thus, we substituted alanine for
either 1, 2, or 3 of these glycines, in all possible combinations, in the
context of the full-length RSV integrase to create seven new proteins
(numbers 2 to 8 in the lower portion of Fig. 1). We refer to the proteins
with single-substitutions as GGA, GAG, and AGG to highlight that one
of the 3 glycines was changed to alanine (proteins 2 to 4 in Fig. 1).
Although not conﬁrmed by structural studies, this region in the
double-substituted proteins (proteins 5 to 7, referred to as AAG, GAA,
or AGA) would be predicted to have less mobility than the single-
substitutions (with AGA having the least ﬂexibility because it has the
glycines at both ends substituted), and the triple-substitution (protein
8, referred to as AAA) would be predicted to be least ﬂexible. We also
designed one mutant that might have greater ﬂexibility than wild-
type by placing a glycine at every position in this region that was not
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that was retained to preserve a kink that might be important for
proper folding or function (protein 9, referred to as “nonPG to G” and
having the sequence 143-GGGPGGGGGG-154).
In contrast to the eight mutants described above, which main-
tained the length of the spacing in the D,D-35-E motif, seven other
mutants altered the size of this region (Fig. 1). Two of these
lengthened the loop by 3 amino acids, either by: (i) inserting a
glycine after each of the preexisting glycines (protein 10, referred to as
“G to GG”), or (ii) inserting 3 glycines after the glycine at 148 (protein
11, referred to as “148+Gx3”). Similarly, two mutants lengthened the
loop by 6 amino acids by: (i) inserting two glycines after each of the
preexisting glycines (protein 12, referred to as “G to GGG”), or (ii)
inserting 6 glycines after Gly-148 (protein 13, referred to as
“148+Gx6”). We also made three mutants that shortened the loop.
One of these (protein 14, “Delta Pro”) removed a single amino acid by
deleting the proline at 147. Another mutant removed 6 amino acids by
deleting every residue except the three glycines and the proline so as
to retain the glycines and the proline that might be needed for
ﬂexibility and looping (protein 15, “Loop = GPGG”). Finally, one
extreme mutant deleted all 10 amino acids in this region (protein 16,
“Delta Loop”). The wild-type and 15 mutated integrase proteins were
all readily expressed in bacteria and puriﬁed under native conditions.
Fourteen of the proteins were puriﬁed at relatively high concentration
and diluted to stock solutions of 4 pmol/μl, and two (nonPG to G and
the Delta Loop) were puriﬁed at 2 pmol/μl. Thus, all assays presented
below compare approximately equimolar amounts (2 to 4 pmol) of
each protein. Importantly, no differences in relative or absolute results
were observed when 2 pmol of every protein were tested in other
experiments (data not shown).Fig. 2. Processing reactions. The schematic at the left depicts the processing assay, in which in
the terminal 2 nucleotides (the asterisk indicates a 32P group). (A) Autoradiogram of process
RSVDNAwere 5′ labeled on the strand that contains the conserved CA and incubatedwith pro
indicated mutated integrases (lanes 2 to 16, corresponding to the proteins in Fig. 1). Reacti
methods. Nucleotide sizes, the 18-mer substrate, and the 16-mer and 15-mer products (reﬂec
converted to 16-mer plus 15-mer plus any joined products (which are derived from processed
from 3 different experiments and are presented beneath the gel. The bars in the graph are ali
shown by a solid bar, mutants designed to have altered ﬂexibility by lightly shaded bars, and
graph. Asterisks highlight mutants that were signiﬁcantly decreased for processing compared
conducted with 5 mM Mg2+ and only 16-mer plus joined products were included in the calEffects of loop mutations on processing
We ﬁrst tested all of the integrase proteins for their ability to
process viral DNA in the presence of Mn2+ because RSV integrase,
similar to other retroviral integrases, exhibits greatest activity with
this metal. Processing is detected as site-speciﬁc shortening of labeled
oligonucleotides that mimic an end of unintegrated viral DNA (Fig. 2,
schematic at the left). It should be noted that avian retroviral
integrases often nick between the conserved C and A nucleotides, as
well as 3′ to the A, when reactions are conducted with Mn2+ (Katzman
et al., 1989). Thus, under these conditions, the wild-type RSV integrase
makes two prominent nicks in the 5′-labeled strand to create 16-mer
and 15-mer products, reﬂecting removal of 2 or 3 nucleotides,
respectively (Fig. 2A, lane number 1; note that the lane with the
negative control reaction conducted with protein buffer is numbered
as lane 0 in this and subsequent ﬁgures).
When tested withMn2+, all but one of the mutant proteins listed in
Fig. 1 were active in the processing assay. In particular, the proteins
designed to have diminished ﬂexibility as a result of substituting one,
two, or three glycines (Fig. 2A, lanes 2 to 8) appeared to be as active as
wild-type. Quantitative analysis of replicate sets of reactions (Fig. 2A,
the graph beneath the gel) showed that the activity of each of these
proteins approached that of the wild-type; only the AAA protein with
three substitutions had a statistically signiﬁcant, though slight,
diminution of activity. In contrast, the protein that was designed to
have increased ﬂexibility showed markedly diminished activity (Fig.
2A, lane 9, nonPG to G; only 21% of wild-type activity, pb0.0001).
Somewhat surprisingly, given the conservation of the 35-amino-acid
spacing, the proteins in which the size of the loop (and thus the
spacing in the D,D-35-E motif) was increased by 3 or 6 amino acidstegrase nicks after conserved CA nucleotides near the 3′ ends of viral DNA and removes
ing assays conducted with Mn2+. Double-stranded 18-mers derived from the U3 end of
tein buffer (the lane numbered as zero), wild-type RSV integrase (lane number 1), or the
ons were conducted in the presence of 10 mM Mn2+ and analyzed as in Materials and
ting nicks at the −2 and −3 sites, respectively) are indicated. The percentages of substrate
products but are not included in the part of the autoradiogram shown) were quantiﬁed
gned with the corresponding lanes from the autoradiogram, with the wild-type protein
the size mutants by darkly shaded bars. The size mutants are also indicated beneath the
towild-type (⁎, pb0.04 and ⁎⁎, pb0.0001). (B) Similar to panel A, except reactions were
culations for processing efﬁciency.
226 W.M. Konsavage Jr. et al. / Virology 379 (2008) 223–233also were very active (Fig. 2A, lanes 10 to 13). Similarly, the proteins in
which the size of the loop was decreased by 1 or 6 amino acids also
showed good activity (Fig. 2A, lanes 14 and 15). Each of proteins 10–15
was approximately 50% to 75% as active as wild-type, although the
modestly decreased activity for each of these proteins reached
statistical signiﬁcance (due in large part to the tight reproducibility
of the data between experiments). The only protein that did not retain
any appreciable activity was the extreme mutant in which all 10
amino acids of the loopwere deleted (Fig. 2A, lane 16). Thus, theMn2+-
dependent processing activity of integrase tolerates many mutations
designed to affect the ﬂexibility or size of this loop in the catalytic
domain.
Avian integrases also readily exhibit processing activity in the
presence of Mg2+. Moreover, with this divalent metal cofactor, the
activity is more speciﬁc for the biologically relevant site that follows
the CA bases (Katzman et al., 1989). Thus, under these conditions, the
wild-type RSV integrase nicks the 5′-labeled strand to create a
predominant 16-mer product (Fig. 2B, lane number 1). Similarly, the
proteins that had one glycine substituted (Fig. 2B; GGA, GAG, and AGG
in lanes 2 to 4, respectively) or one of the ﬂanking glycines plus the
internal glycine substituted (AAG or GAA in lanes 5 and 6) were active
for processing, although the activities of these proteins (especially
those with two substitutions) were diminished (Fig. 2B, the graph
beneath the gel). In contrast, activity was not detected for the proteins
with both ﬂanking glycines substituted (AGA and AAA in lanes 7 and
8) or the protein designed to have increased ﬂexibility (nonPG to G in
lane 9). Moreover, and in contrast to the results withMn2+, none of the
size mutants catalyzed processing in the presence of Mg2+ (Fig. 2B,
lanes 10 to 16). Thus, compared to reactions with Mn2+, the Mg2+-Fig. 3. Joining reactions. The schematic at the left depicts the joining assay, inwhich integrase
radiolabeled products longer than the substrate (the asterisks indicate 32P groups). (A) A
representing the preprocessed U3 end of RSV DNA were 5′ labeled on the strand that conta
conducted in the presence of 10mMMn2+ and analyzed as inMaterials andmethods. The 30-
converted to joined products were quantiﬁed from 5 experiments and are presented grap
autoradiogram (the shading of the bars is as in the legend to Fig. 2). Asterisks highlight mutan
pb0.0001). (B) Similar to panel A, except reactions were conducted with 5 mM Mg2+.dependent processing activity of RSV integrase was less tolerant of
marked changes in the ﬂexibility of the loop, or of any changes in the
size of the loop (and the spacing) within the D,D-35-E catalytic region.
Effects on DNA joining
To assess how the proteins catalyzed DNA joining, we used a
preprocessed substrate representing 32 base pairs from one end of
RSV DNA but with 2 nucleotides 3′ to the conserved CA already
removed (Fig. 3, schematic at the left). In reactions conducted with
Mn2+, joined products greater than 30 nucleotides in length were
evident for the wild-type and many of the substituted proteins. In
particular, all of the mutants designed to have diminished ﬂexibility
were very active (Fig. 3A, lanes 2 to 8, and shown quantitatively
beneath the gel), and some even seemed more active than wild-type.
In contrast, the protein designed to have increased ﬂexibility exhibited
greatly diminished activity (Fig. 3A, lane 9, pb0.0001 compared to
wild-type; note that joined products are evident on the original ﬁlm).
The proteins in which the loop was lengthened by 3 or 6 amino acids
that were distributed at three locations in the loop (“G to GG” and “G
to GGG” at residues 145, 148, and 152) also showed diminished
activity (Fig. 3A, lanes 10 and 12). However, the activity of the proteins
inwhich 3 or 6 glycines were inserted at one location after residue 148
were not as impaired (Fig. 3A, lanes 11 and 13, reproducibly decreased
but still N40% of wild-type activity). Similarly, the protein inwhich the
size of the loop was decreased by 1 amino acid also exhibited N40% of
wild-type activity (Fig. 3A, lane 14). Even the protein in which the size
of the loopwas decreased by 6 amino acids retained some activity (Fig.
3A, lane 15, 13% of wild-type activity). The only protein that did notinserts processed viral DNA ends into various sites on either DNA strand to yield a set of
utoradiogram of joining assays conducted with Mn2+. Double-stranded 30/32-mers
ins the conserved CA and incubated with the same proteins as in Fig. 2. Reactions were
mer substrate and the longer joined products are indicated. The percentages of substrate
hically beneath the gel, with the bars aligned with the corresponding lanes from the
ts that were signiﬁcantly decreased for joining compared towild-type (⁎, pb0.03 and ⁎⁎,
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residues of the loop were deleted (Fig. 3A, lane 16).
When reactions were conducted with Mg2+, a cation with which
joining is generally less efﬁcient, additional differences were noted.
The mutants designed to have diminished ﬂexibility as a result of
substituting one or two of the glycines by alanine all retained some
joining activity (Fig. 3B, lanes 2 to 7, and shown quantitatively below
the gel), but all were diminished compared to wild-type (pb0.0001).
In contrast, joining was not detected for the protein designed to have
the least ﬂexibility (Fig. 3B, lane 8) or the protein designed to have
increased ﬂexibility (lane 9). Additionally, none of the size mutants
catalyzed joining in the presence of Mg2+ (Fig. 3B, lanes 10 to 16). Thus,
as with processing, the size of the spacing in the D-35-E region
appears more important then the ﬂexibility of the loop for catalyzing
joining. Together, these results indicate that the processing and
joining activities of integrase can tolerate many changes that are
predicted to alter the ﬂexibility or length of the loop within the D,D-
35-E catalytic region, but fewer changes are tolerated with Mg2+ than
with Mn2+.
Effects on other enzymatic activities of integrase
As mentioned, integrase can catalyze two other in vitro nicking
reactions: disintegration and nonspeciﬁc alcoholysis (Chow et al.,
1992; Katzman and Sudol,1996). Because these activities are exhibited
by the isolated central domain of the protein (Bushman et al., 1993;
Katzman and Sudol, 1996), they provide a useful way to assess the
integrity of the catalytic region of the enzyme in the context of the full-
length protein. In particular, disintegration reﬂects the ability of
integrase to reverse the joining reaction (Chow et al., 1992). In this
assay, a complex of four oligonucleotides that mimic the product of aFig. 4. Disintegration reactions. The schematic at the left depicts the disintegration assay, w
labeled 16-mer substrate to a 31-mer product (the asterisk indicates a 32P group); some of th
create bands migrating at intermediate positions. (A) Autoradiogram of disintegration assays
U3 DNA end attached to cellular DNA was incubated with the same proteins as in Fig. 2 in t
quantiﬁed from 2 experiments and are presented beneath the gel (the alignment and shadin
wild-type with pb0.004. (B) Similar to panel A, except reactions were conducted with 5 mMjoining reaction serves as the substrate, and disintegration is
manifested as the conversion of a radiolabeled 16-mer to a 31-mer
(Fig. 4, schematic at the left).We found that thewild-type and all of the
integrase mutants except the Delta Loop catalyzed this activity in the
presence of Mn2+ (Fig. 4A, lanes 1 to 15, and shown quantitatively
beneath the gel). It should be noted that the bands migrating between
the 16-mer and 31-mer positions are included in the quantitation of
disintegration activity because these bands have been shown to be
created by nonspeciﬁc nicking of the 31-mer disintegration product
(Kulkosky et al., 1995; Vink et al., 1993) or by reinsertion of the
processed viral DNA ends that are released by the disintegration
reaction (Vincent et al., 1993). Why the wild-type was less active than
several of the mutant proteins in these particular experiments is
unclear (indeed, in the autoradiogram presented, little of the product
created by the wild-type is visible at the 31-mer position). However,
the point of these experiments was to test the function of the integrase
mutants, and the results clearly show that the catalytic region of all of
these proteins except the Delta Loop retains a functional conformation.
RSV integrase also exhibits disintegration activity in the presence
of Mg2+.We found that with this divalentmetal cofactor, thewild-type
and the mutants designed to decrease the ﬂexibility of the loop all
retained activity (Fig. 4B, lanes 1 to 8), although the amount of activity
was somewhat reduced for proteins 4, 5, and 8 (AGG, AAG, and AAA,
respectively). In contrast, the protein designed to have increased
ﬂexibility exhibited markedly diminished activity (Fig. 4B, lane 9,
pb0.0001). Similarly, all of the size mutants were dramatically
impaired for disintegration activity in the presence of Mg2+ (Fig. 4B,
lanes 10 to 16), although only the Delta Loop mutant was completely
devoid of any detectable activity.
We also tested these proteins in the nonspeciﬁc alcoholysis assay,
which – similar to joining – reﬂects the ability of integrase to nickhich is a reversal of the joining reaction and seals the nick in nonviral DNA to convert a
e 31-mer products are subsequently shortened by integrase, as discussed in the text, to
conducted with Mn2+. A 4-oligonucleotide complex representing the product of the RSV
he presence of 10 mM Mn2+. The percentages of substrate converted to products were
g of the bars are as in the legend to Fig. 2). The asterisk indicates a decrease compared to
Mg2+. ⁎, pb0.01 and ⁎⁎, pb0.0001.
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Skinner et al., 2001). For this activity, which is evident only with Mn2+,
integrase uses water or certain alcohols as the attacking nucleophile to
nick almost any internal site in DNA (Fig. 5, schematic at the left). The
wild-type RSV integrase nicked N80% of the DNA substrate in this
assay (Fig. 5, lane number 1). Although the nonspeciﬁc nicking activity
of each of the mutants was decreased (pb0.0001 vs. wild-type, as
shown at the bottom of Fig. 5), only two of the proteins can be
characterized as having minimal activity. In particular, the protein
designed to have increased ﬂexibility (Fig. 5, lane 9) and the protein
missing the loop (lane 16) had ≤5% of wild-type activity. Perhapsmore
importantly, it is worth noting that all of the size mutants except theFig. 5. Nonspeciﬁc alcoholysis reactions. As depicted schematically at the left, integrase
uses certain alcohol groups to nick nonviral DNA at any of various sites (the asterisk
indicates a 32P group). (A) Double-stranded 23-mers of nonviral sequence were 5′
labeled on one strand and incubated with the same proteins as in Fig. 2. Reactions
contained 10 mMMn2+ and 20% glycerol. The 23-mer substrate and nicked products are
indicated, as are nucleotide sizes of particularly prominent products from the wild-type
protein. The percentages of substrate that received at least 1 nick were calculated for
each protein from 3 experiments and are presented beneath the gel (the alignment and
shading of the bars are as in the legend to Fig. 2). The double asterisks indicate a
decrease compared to wild-type with pb0.0001.Delta Loop readily exhibited this Mn2+-dependent enzymatic activity
(Fig. 5, lanes 10 to 15). Together, the results of the disintegration assay
(with two metals) and the nonspeciﬁc nicking assay (with one metal)
indicate that the catalytic function of integrase can withstand many
changes predicted to alter the ﬂexibility or length of the mobile loop,
but – as with processing and joining – fewer changes are tolerated
with Mg2+ than with Mn2+.
Virus infections
To provide biological correlation for the in vitro ﬁndings, we
moved several of the integrase mutants that were inactive for at least
one of the biologically relevant actions of integrase (i.e., processing
and joining) into an infectious clone of RSV to test their effects
during infections. We selected from among proteins 7 to 16, which
were inactive for Mg2+-dependent processing (Fig. 2B); of these,
proteins 8 to 16 were also inactive for Mg2+-dependent joining
(Fig. 3B). Because we were particularly interested in the metal-
dependent discordance that depended onwhether Mn2+or Mg2+ was
present during reactions, we did not further pursue protein 16
(which was inactive with either metal and likely is grossly distorted
due to removal of the entire loop between residues 143 and 154). Of
the two proteins that lengthened the loop by 3 amino acids (proteins
10 and 11), we selected protein 10 (which distributed the insertions
at 3 positions along the loop) for further study. Similarly, of the two
proteins that lengthened the loop by 6 amino acids (proteins 12 and
13), we chose to study protein 12 for the same reason. Thus, proteins
7 and 8 (which were designed to decrease the ﬂexibility of the loop),
protein 9 (designed to increase ﬂexibility), proteins 10 and 12 (which
lengthened the loop), and proteins 14 and 15 (which shortened the
loop) were all transferred into an infectious clone of RSV that
encodes green ﬂuorescent protein. Supernatants of cells transfected
by the wild-type or mutant plasmids were then equalized for reverse
transcriptase activity and used to infect a susceptible chicken cell
line, and spread of infection was monitored by measuring the
percentage of cells that were ﬂuorescent. Whereas the wild-type
virus rapidly spread through the culture, infecting essentially 100%
of the cells by day 7, replication was not detected for any of the
mutant viruses (Fig. 6). Identical results were observed in two
experiments and with two different clones of each mutant. Thus,
virus replication for these integrase mutants correlated with the
results of processing or joining assays conducted with Mg2+.
We next localized the block to replication for the defective viruses
by measuring the amounts of circular viral DNA that contains tandem
long terminal repeats (LTRs) in cells soon after exposure to these
viruses. Though not considered an intermediate in virus replication, 2-
LTR circles are widely accepted as a marker for nuclear entry of
preintegration complexes in the RSV (and HIV) systems (Bukrinsky et
al., 1992; Katz et al., 2002). Detection of 2-LTR circles indicates that all
events leading up to integration have occurred, and the amount of
these DNA forms are normal or increased when there is a block at the
integration step (Engelman et al., 1995; Leavitt et al., 1996;
Wiskerchen and Muesing, 1995). Indeed, each of the mutant viruses
that was replication-defective in Fig. 6 yielded an increased amount of
2-LTR circular DNA compared to wild-type virus (the autoradiograms
in Fig. 7, which also show ampliﬁcation of mitochondrial DNA as an
internal control for input DNA). Similar results were obtained from 3
different experiments (i.e., 3 sets of transfections followed by
infections and PCR analysis), as shown in the bar graph in Fig. 7
(pb0.001 for eachmutant compared towild-type). Repeating the PCRs
with serial dilutions of each sample conﬁrmed the quantitation
reﬂected in Fig. 7 (data not shown). These results indicate that these
viruses, which contain integrase mutations that interfere with Mg2+-
dependent processing or joining in vitro, are blocked at the integration
step during infections (Engelman, 1999), although we cannot exclude
an additional defect in particle assembly or release (Lu et al., 2005).
Fig. 7. PCR for 2-LTR circles. Supernatants were collected from QT6 quail cells
transfected by wild-type or the indicated mutant plasmids, equalized for reverse
transcriptase activity, and used to infect DF-1 chicken cells; supernatant from a mock
transfection was included as a negative control for the infections. Hirt supernatants
were collected the next day and analyzed by PCR using primers that amplify the LTR-LTR
junction (the upper autoradiogram) or chicken mitochondrial DNA (the lower
autoradiogram), as in Materials and methods. Sizes in base pairs, as conﬁrmed by
molecular mass markers, are indicated. The amounts of 2-LTR products were corrected
for input DNA (the mitochondrial signal) and then compared to the wild-type in 3
different experiments, as presented in the graph at the bottom (the bars are aligned
with the corresponding lanes in the autoradiograms, and protein numbers and shading
of the bars are as in Fig. 2). The value of 1 is shown by a horizontal line, and asterisks
indicate that results from all of these mutants were increased compared to wild-type
with pb0.001.
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The catalytic domain of retrovirus integrases has several char-
acteristic features, including: (i) three conserved acidic amino acids;
(ii) the arrangement of these residues into a D,D-35-E motif; and (iii)
the presence of a disordered or mobile loop within the 35-amino-acid
spacer. Elucidating the functions of these features is of obvious
importance for understanding the mechanism of this enzyme and for
designing effective inhibitors for clinical use. Crystallization studies
indicate that the conserved acidic residues coordinate the one or two
divalent metal cations required for enzyme activity (Bujacz et al.,
1997; Bujacz et al., 1996; Goldgur et al., 1998; Maignan et al., 1998),
and biochemical studies support these ﬁndings (Diamond and
Bushman, 2006). The conservation of the 35-amino-acid spacing in
retroviral integrases is remarkable, especially considering that the
analogous spacing in related enzymes from retrotransposons can be a
few amino acids shorter or longer than 35 (Doak et al., 1994; Khan et
al., 1991; Kulkosky et al., 1992), that it can vary greatly in bacterial
insertion sequence elements (Haren et al., 1999), and that this spacing
in bacteriophage Mu transposase is 55 amino acids (Krementsova
et al., 1998).
The role of the disordered or ﬂexible loop is also unclear, but it has
been implicated in interactions between integrase and viral DNA
(Esposito and Craigie, 1998; Gerton et al., 1998; Johnson et al., 2006) or
between integrase and both viral and cellular DNA (Heuer and Brown,
1997; Wielens et al., 2005). Substitutions in this loop can also affect
interactions with the attacking nucleophilic donor that is used to nick
DNA during catalysis (van den Ent et al., 1998; van Gent et al., 1993).
Interestingly, substitutions at two conserved residues in the avian
retroviral loop (I146A and Q151R, corresponding to HIV-1 residues
I141 and Q146) had minor or no effect on any in vitro activities
(Moreau et al., 2002). On the other hand, published data indicate that
ﬂexibility of this loop is important for enzyme function. For example,
this loop becomes more ordered when crystals of the central domain
of ASV integrase are bound to an integrase inhibitor (Lubkowski et al.,
1998b) or adjusted to low pH conditions at which the enzyme is
inactive (Lubkowski et al., 1999; Lubkowski et al., 1998a). Similarly,
substituting alanine for the glycines at HIV-1 integrase residues 140
and 149 – which ﬂank the loop and were suggested to act as
conformational hinges – decreased the mobility of this loop in crystals
of the central domain and diminished the activity of this fragment
when it was tested in disintegration assays (Greenwald et al., 1999).
Molecular dynamics simulations also reveal decreased loop mobility
in these mutants (Lee et al., 2005) and show that inhibitors make the
loop less ﬂexible in wild-type integrase but not in a drug-resistant
mutant (Barreca et al., 2003; Brigo et al., 2005a; Brigo et al., 2005b).
Based on these reports, we decided to manipulate the ﬂexibility of
the loop, as well as its length, in the context of a full-length integraseFig. 6. Virus replication assay. Supernatants of QT6 quail cells transfected by wild-type
or selected mutant plasmids were collected, equalized for reverse transcriptase activity,
and used to infect DF-1 chicken cells. Spread of infection was monitored by analysis of
cultures at each time point using an automated ﬂuorescence-activated cell sorter. Each
virus (as indicated by integrase mutation and corresponding protein number) was
tested at least 3 times.that could be tested in a range of integrase assays. Although we refer
to integrase mutants in which the loop was lengthened or shortened
as size mutants, we have been careful not to refer to the other proteins
as ﬂexibilitymutants because proof of that term is beyond the scope of
this report. Nonetheless, there is little reason to expect that these
loops act differently in the integrases from HIV-1 and RSV (Lins et al.,
2000). Thus, given the correlation between diminished ﬂexibility and
loss of activity for the HIV-1 enzyme, it was somewhat surprising that
full-length RSV integrases with similar mutations retained robust
processing and joining activity (Figs. 2A and 3A, proteins 2 to 8);
however, this statement was only true for reactions conducted with
Mn2+. In contrast, Mg2+-dependent processing activity correlated with
the predicted decrease in ﬂexibility; i.e., it was greatly impaired for
RSV integrases in which one of the ﬂanking glycines and an internal
glycine were simultaneously replaced by the more-constrained
alanine (Fig. 2B, proteins 5 and 6), and it was not detectable when
both of the ﬂanking glycines were replaced (Fig. 2B, proteins 7 and 8).
Similarly, although Mg2+-dependent joining was impaired for all
proteins designed to have diminished loop ﬂexibility, the protein with
all three glycines substituted had no detectable activity (Fig. 3B,
protein 8). Why protein 7 (AGA) retained some joining – but not
processing – activity with Mg2+ is unclear, but it suggests that
ﬂexibility is particularly important for processing viral DNA. It also is
possible that this protein achieves a more functional conformation
when bound to two DNA substrates for joining, which is consistent
with protein 7 being the most active protein for Mg2+-dependent
disintegration (Fig. 4B). However, we have not excluded the possibility
that the activity proﬁle of the AGA protein was due to an extraneous
A18S substitution (an unplanned mutation noted in Fig. 1 and the
Materials and methods), but that explanation seems unlikely.
Signiﬁcantly, our data suggest that ﬂexibility of the loop is
important for processing and joining only when Mg2+ is present; the
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to 8) diminished the ﬂexibility of the loop seems unlikely. The ability
of proteins 2 to 8 to catalyze disintegration with Mg2+ (Fig. 4B) also
tells us that fatal distortion of the active site that manifests only when
Mg2+ is present cannot explain these ﬁndings. Thus, ﬂexibility of the
loop is likely to be important for positioning the substrate DNA and
the attacking nucleophilic donor, a positioning event that is
circumvented by the preformed disintegration substrate. On the
other hand, protein 9 (nonPG to G) was impaired with either divalent
metal. Moreover, the relative impairment of this protein was still
evident if the concentrations of the other proteins were reduced by
50% in all reactions (data not shown). However, any conclusion that
increased ﬂexibility is detrimental to enzyme activity remains
speculative at this point, given that only one such protein was tested
and the lack of structural data to support the notion that this mutant
(or an analogue) has increased ﬂexibility.
Unlike the inferences about ﬂexibility, we can be certain that the
length of the loop was altered in each of the size mutants. Thus, it is
remarkable that proteins in which this loop was increased or
decreased by up to 6 amino acids showed robust processing activity
in the presence of Mn2+ (Fig. 2A, proteins 10 to 15). These proteins also
had readily detectable – though clearly diminished – joining activity
with the same cation (Fig. 3A, proteins 10 to 15). However, none of
these proteins exhibited processing or joining with Mg2+ (Figs. 2B and
3B). Moreover, all of these proteins were dramatically impaired for
Mg2+-dependent disintegration (Fig. 4B). Hence, the 35-amino-acid
spacing is not absolutely required for enzyme activity, but this precise
spacing is correlatedwith activity in reactionswithMg2+. Additionally,
no virus containing an integrase with altered length replicated in cell
cultures (Fig. 6), and the defect for these viruses was localized to the
integration step (Fig. 7). Thus, the conserved spacing within the D,D-
35-E catalytic domain of integrase appears to be absolutely required
for retrovirus replication. The data also suggest that the conserved
spacing is needed for enzyme activity during infections, although we
cannot exclude the possibility that this precise spacing is required for
protein-protein interactions that are necessary for integration or some
other biological function.
To our knowledge, only one other report included experiments
that altered the spacing in the D,D-35-E motif. Puglia et al. made a
series of 19-amino-acid insertions across HIV-1 integrase and
analyzed these proteins in disintegration and DNA joining assays
using Mn2+ (Puglia et al., 2006). In particular, they reported that none
of 13 proteins with an insertion anywhere within the D,D-35-E motif
catalyzed DNA joining, although a few (including two with insertions
in the 35-amino-acid spacer) retained low levels of disintegration
activity. They also placed a series of 5-amino-acid insertions across
Moloney murine leukemia virus integrase within the context of a
proviral construct, and found that none of 26 mutant viruses with
insertions in the D,D-35-E motif were viable, including several with
insertions in the 35-amino-acid spacer. Thus, our data support and
extend those ﬁndings and underscore the stringent biological
requirement for this precise spacing for successful integration during
virus infections.
Given that the ﬂexible loop has been implicated in binding DNA
(Esposito and Craigie, 1998; Gerton et al., 1998; Heuer and Brown,
1997; Johnson et al., 2006; Wielens et al., 2005), we also tested the
DNA-binding properties of the integrase mutants described in this
report. We found that all of the proteins were able to be UV-
crosslinked (Konsavage et al., 2007) to viral or nonviral DNA in the
presence of Mn2+ or Mg2+, and while some quantitative differences
were noticed, there was no obvious correlation between DNA binding
and enzyme activity (data not shown). Although more work is needed
to understand the roles of the ﬂexible loop in integrase function, our
data argue against a role in choosing cellular-DNA target sites. In
particular, none of the mutations changed the pattern of joined
products in Fig. 3 (using either metal) or the pattern of nickedproducts in Fig. 5, both of which reﬂect site preferences when nicking
nonviral DNA. Even the proteinmissing the entire loop created a small
amount of nicked products in the nonspeciﬁc alcoholysis assay that
reﬂected the same preferences as wild-type protein (Fig. 5, protein 16,
note the 19-, 15-, 12-, and 8-mer products). These ﬁndings are in stark
contrast to our demonstration that many substitutions at RSV
integrase residue 124 (and HIV-1 residue 119) determined which
nonviral target DNA sites were selected by integrase in joining and
nonspeciﬁc nicking assays (Harper et al., 2001; Harper et al., 2003). On
the other hand, our results underscore an important interaction of the
ﬂexible loop with the divalent metal cofactor that binds to the
conserved acidic residues. This conclusion is consistent with the
ﬁndings that many integrase inhibitors chelate divalent metals
(Courcot et al., 2007; Grobler et al., 2002; Kawasuji et al., 2006;
Neamati et al., 1998; Sechi et al., 2006; Tchertanov and Mouscadet,
2007) and that many integrase inhibitors interact with the ﬂexible
loop (Goldgur et al., 1999; Lee and Robinson, 2006; Lubkowski et al.,
1998b; Sotriffer et al., 2000).
What do our new data tell us about the enzymology of integrase,
both in vitro and in vivo? Because avian retroviral integrases readily
exhibit activity in the presence of Mg2+ without needing augmenting
reagents such as dimethyl sulfoxide (Morgan and Katzman, 2000),
they provide a unique system for studying the metal requirements for
activity. Even though many puriﬁed integrases have minimal or no
activity with Mg2+ under standard reaction conditions (Avidan and
Hizi, 2008; Craigie et al., 1990; Katzman and Sudol, 1994; Muller and
Krausslich, 1999; Pahl and Flugel, 1993; Snasel et al., 2005; Vink et al.,
1994), this metal is generally assumed to be physiologically relevant
because it is more abundant than Mn2+ within cells (Asante-Appiah
and Skalka, 1997; Sechi et al., 2006). It has been suggested that the
greater activity of puriﬁed integrases with Mn2+ is not due to
differences in catalytic activity with the two metals, but reﬂects a
greater ability of Mn2+ to stabilize integrase-viral DNA complexes;
presumably other factors facilitate the formation of functional
complexes in vivo (Pemberton et al., 1996). Indeed, preintegration
complexes isolated from cells are competent for in vitro integration in
the presence of Mg2+ (Brown et al., 1987; Ellison et al., 1990; Farnet
and Haseltine, 1990; Fujiwara and Craigie, 1989). Thus, it is signiﬁcant
that we have now created several novel mutants of RSV integrase in
which activity with Mg2+ is selectively abolished. Compared to
divalent magnesium, divalent manganese has a slightly larger radius,
may have a slightly more ﬂexible coordination sphere, is considered
softer (i.e., more polarizable), binds more frequently to nitrogen,
commonly binds only 2 water molecules, binds water more weakly,
does not polarize water as well, and can form bidentate carboxylate
complexes (Bock et al., 1999); Mn2+ also tolerates a wider range of
reactive group geometries or alignment (Huang et al., 1997) and
relaxes the speciﬁcity of many enzymes (Hsu and Berg, 1978; Vermote
and Halford, 1992). Any or all of these factors could contribute to our
mutants being selectively impaired with Mg2+. Importantly, however,
no virus with any integrase mutation that selectively impaired activity
with Mg2+ was able to replicate, and these viruses had a defect at the
integration step. Thus, these functional and genetic data provide new
experimental support for the long-standing presumption that Mg2+ is
the biologically relevant divalent metal used by integrase during
infections.
Materials and methods
Protein expression and puriﬁcation
The RSV integrase used for these studies, as described in detail
previously (Konsavage et al., 2005), was encoded by a derivative of
plasmid pBH RCAN-HiSV (Dong et al., 1992) and expressed from the
pQE-30 plasmid (Qiagen, Inc., Chatsworth, CA). Mutations were
introduced with the QuikChange site-directed mutagenesis system
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by sequencing the entire integrase-coding region; only one protein
used in these studies (protein 7: AGA) was noted in retrospect to have
an unplanned mutation (A18S), as indicated in the legend to Fig. 1. All
proteins were expressed in Escherichia coli M15[pREP4] (Qiagen),
puriﬁed by metal afﬁnity chromatography under native conditions,
and quantiﬁed and stored as previously described (Konsavage et al.,
2007).
Processing, joining, disintegration, and nonspeciﬁc alcoholysis assays
The sequences of all oligonucleotides used in these assays have
been published (Konsavage et al., 2005). Oligonucleotides were gel-
puriﬁed following synthesis and again after being 5′ labeled with
[γ32 P]ATP by T4 polynucleotide kinase, as described (Katzman and
Sudol,1995). All integrase assays were conducted for 90min at 37 °C in
10-μl reaction mixtures that contained 0.5 pmol of double-stranded
DNA (or 0.1 pmol of the disintegration substrate), 25 mM Tris–HCl (pH
8.0), 10 mM dithiothreitol, 10 mMMnCl2 or 5 mMMgCl2, and 1.0 μl of
integrase (containing 2 to 4 pmol of enzyme) or protein storage buffer,
then analyzed on 20% polyacrylamide (acrylamide to methylene-
bisacrylamide ratio, 19:1) −7 M urea denaturing gels; these methods
all have been described previously (Konsavage et al., 2007).
Results were quantiﬁed from gels inwhich the reaction lanes were
separated by empty lanes by using a Phosphorimager (Molecular
Dynamics, Sunnyvale, CA) at the Penn State College of Medicine
Macromolecular Core Facility. Yields of various products were
calculated using phosphorimager units for the entire gel lane as the
denominator, and corrections weremade for control reactions that did
not contain integrase (Morgan and Katzman, 2000). Statistical
comparisons were performed with SAS Version 9.1 using a blocked
analysis of variance (ANOVA) with Dunnett's multiple comparison
procedure to compare each protein to the wild-type, with the day of
the experiment as the blocking factor and two-sided p-values. The
ANOVA approach allows for use of all the data simultaneously, hence
an improvement in statistical power over the Student's t-test function
(although use of the Student's t-test would not alter any conclusions
from this report). All results are presented as the mean±standard
error of replicate reactions.
Virus infections
Virus infections were conducted as described (Konsavage et al.,
2007). Brieﬂy, viruses were prepared from an RCASBP(A) derivative in
which the src genewas replaced by the gene encoding green ﬂuorescent
protein (Schaefer-Klein et al., 1998), which we further modiﬁed by a
silent mutation to destroy a Bgl II site within the gag gene (Konsavage et
al., 2005). Integrase mutations were introduced by inserting the Bgl II/
Kpn I fragment of the corresponding pQE-30-integrase plasmid, and
DH5α bacteria were transformed with the proviral constructs. The
integrase-coding region of theplasmidspuriﬁed from two colonieswere
sequenced to exclude extraneousmutations; two clones for eachmutant
were used to reduce the possibility that any observed virus phenotype
was due to mutations outside of integrase. QT6 quail cells (Moscovici et
al., 1977) were transfected with wild-type or mutant DNA, and virus-
containing supernatants were collected after 48 h. Virus was quantiﬁed
by reverse transcriptase activity, and equal counts perminutewere used
to infect DF-1 chicken cells (Schaefer-Klein et al., 1998). Cell cultures
were passaged every 3 or 4 days, and the spread of infection was
assessed by measuring the percentage of cells that were ﬂuorescent
using anautomatedﬂuorescence-activated cell sorter (FACS) in the Penn
State College of Medicine Flow Cytometry Core Facility. Although the
volumes of supernatant required to equalize the input virus for the
infections varied between experiments, eachmutant yieldedmore than
50% of the wild-type reverse transcriptase activity in at least one
transfection.Detection of circular viral DNA that contains tandem LTRs
Virus infections were conducted as above, and Hirt supernatants
from one 60-mm dish were collected 18 h after infection (Hirt, 1967).
The DNAwas extracted with phenol and chloroform, precipitatedwith
alcohol, and resuspended in a 10-μl volume. One microliter of each
sample was used for PCR with primers that amplify the LTR-LTR
junctions present in some circular forms of unintegrated DNA (Katz et
al., 2002). To control for the amount of DNA recovered from the cells,
1 μl of each sample was also used for a separate PCR with primers that
amplify chickenmitochondrial DNA (Spidel et al., 2007); we had found
that the efﬁciency of ampliﬁcation was greater when these primer
pairs were not mixed in the same reaction. Each PCR included one 5′
32P-labeled primer and was conducted as described (Konsavage et al.,
2007), except that 2.5 U of Taq DNA polymerase were used and
ampliﬁcation was continued for only 28 cycles (note that we
established that the amount of products from either primer pair did
not begin to plateau until after 31 cycles). Samples were loaded onto
8% polyacrylamide (acrylamide to methylene-bisacrylamide ratio,
37.5:1) nondenaturing gels, followed by electrophoresis at 200 V until
the bromophenol blue dye had migrated 10 cm, and the gels were
dried, autoradiographed at −70 °C, and quantiﬁed by phosphorima-
ging. In each experiment, the signal for the 2-LTR products was
divided by the corresponding signal for mitochondrial DNA (to correct
for the amount of DNA recovered from the infections), and the results
for each mutant were normalized to that of the wild-type virus.
Statistical analysis was as described above except that the data were
log-transformed because ratios were being compared.
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